Andrew S. Furlow
Andrew Furlow is a trusted adviser to providers, drug and device manufacturers, and other key players in the healthcare industry. He works with healthcare companies to shape and respond to new and strategically important legislation, saving crucial time and resources.
Andrew is an authority on topics such as the Open Payments disclosure law, the branded prescription drug fee, and Medicare value-based payment programs. He has helped clients to influence and make sense of these new laws even before they hit the statute books. Whether counseling a three-person start-up or a company with a dozen lines of business, Andrew provides regulatory and strategic guidance that goes to the heart of the issue and offers practical steps to move forward. He has helped clients build compliance programs from the ground up and craft meticulous responses to enforcement actions, and delivers fast, focused advice when an experienced company needs a gut check as it enters uncharted risk territory.
Andrew clerked for the Honorable David F. Hamilton on the United States Court of Appeals for the Seventh Circuit and the United States District Court for the Southern District of Indiana. He received his J.D. from Harvard Law School, where he served as an Executive Editor on the Harvard Law Review.